Abstract:Prostate cancer (PCa) is the second leading cause of death in men. Recently, some researches have showed that 5α-reductase inhibitors were beneficial in PCa treatment as well. In this study, a series of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives have been designed and synthesized in a more simple and convenient method. Most of the synthesized compounds displayed good 5α-reductase inhibitory activities and androgen receptor binding affinities. Their anti-proliferation activities in PC-3 and LNCaP cell lines were also evaluated and the results indicated that most of the synthesized compounds exhibited potent anti-proliferative activities. It is obvious that the androgen-dependent cell line LNCaP was much more sensitive than the androgen-independent cell line PC-3. Among all the synthesized compounds, 11d and 11k displayed the best inhibition activity with 4-fold more sensitive toward LNCaP than PC-3, which was consistent with their high affinities observed in AR binding assay. Molecular modeling studies suggested that 11k could bind to AR in a manner similar to the binding of dihydrotestosterone to AR. Compared to the finasteride, 11k showed a longer plasma half-life (4h) and a better bioavailability. Overall, based on biological activities data, compound 11d and 11k can be identified as potential dual 5α-reductase inhibitors and AR antagonists which might be of therapeutic importance for prostate cancer treatment.

Synthesis of 3-Oxo-4-aza-5-androstene-17-oxime Derivatives

Synthesis and 5 alpha-Reductase Inhibition Activity Evaluation of 3-Keto-4-aza-Delta(5)-androstene-17-oximido Derivatives

Synthesis of N-Substituted 3-Oxo-17b- Carboxamide-4-aza-5a-androstanes and the Tautomerism of 3-Oxo-4-aza-5-androstenes

Synthesis of (5Α)-17-azaandrostan-3-ols and (5Α)-17-aza-d-homoandrostan-3-ols and Their N-acylated Derivatives

Synthesis of Novel Chiral 7-Amide Substituted-4-Androstene-3,17-Dione Derivatives

Synthesis and Antitumor Activity of 17-(2 ',5 '-Disubstituted-oxazolyl)-androsta-4, 16-Dien-3-one Derivatives

Preparation of (5Α,13α)-D-azasteroids As Key Precursors of a New Family of Potential GABAA Receptor Modulators

Synthesis of novel D-ring fused 7'-aryl-androstano[17,16-d][1,2,4] triazolo[1,5-a]pyrimidines.

Design, Synthesis and Biological Evaluation of Novel Androst-3,5-diene-3-carboxylic Acid Derivatives As Inhibitors of 5Α-Reductase Type 1 and 2

Design, Synthesis and Biological Evaluation of Novel 3-Oxo-4-oxa-5α-androst-17β-amide Derivatives As Dual 5Α-Reductase Inhibitors and Androgen Receptor Antagonists.

Design, Synthesis, Brine Shrimp Lethality and Cytotoxicity of Some Novel 17A-Aza-d-homo-androster-17-one Derivatives

Syntheses of Some 17-Heterocyclic Substituted Androstene Derivatives as Inhibitors of Human 17α-Hydroxylase/C17,20-layse(P45017α)

Significant Steroids: Effective and General Synthesis of 4 Alpha- and 4 Beta-Amino-5 Alpha-Androstanes

Improved Synthesis of 17-(5′-isoxazolyl)androst-4,16-dien-3-one,a Potential Agent for the Treatment of Prostate Cancer

[Synthesis and Antifertility Activity of A-nor-5 Alpha-Androstane Derivatives].

Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives

First Synthesis of 22-Oxa-chenodeoxycholic Acid Analogue

An efficient synthesis of 5alpha-androst-1-ene-3,17-dione.

An Efficient Synthesis of 5Α-Androst-1-ene-3,17-dione

Synthesis and Characterisation of Novel 4-Chloro-16e-benzylidene Steroidal Derivatives

Novel P45017α inhibitors: 17-(2′-oxazolyl)- and 17-(2′-thiazolyl)-androstene derivatives